Data / Form D filings / BIOCUREX INC
BIOCUREX INC: Form D filings
BIOCUREX INC, a biotechnology company in Richmond, filed 3 Form D notices with the SEC in 2009. The latest, on November 9, 2009, reports $2.2 million sold of a $2.2 million offering to 2 investors.
Find out what BIOCUREX INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7080 RIVER RD, SUITE 215, Richmond, V6X 1
- Phone
- (866) 884-8669
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- British Columbia, Canada
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506, Securities Act section 4(6)
- SEC identifier (CIK)
- 1092562
The full lists. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 9, 2009 | New notice | $2,150,000 | $2,150,000 | $0 | 2 | Aug 31, 2009 | sec.gov |
| Oct 6, 2009 | New notice | $125,000 | $125,000 | $0 | 3 | Sep 29, 2009 | sec.gov |
| Sep 22, 2009 | New notice | $450,000 | $450,000 | $0 | 17 | Sep 10, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| DENIS BURGER | Director, Executive Officer | |
| PHIL GOLD | Director | |
| ANTONIA BOLD-DE-HAUGHTON | Director | |
| JIM WALSH | Director | |
| RICARDO MORO-VIDAL | Executive Officer | |
| GLADYS CHAN | Executive Officer |
Every Form D from the week of Nov 9, 2009 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BIOCUREX INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.